No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 205-208

  Hirate, Kenji ^a   Hirano, Masuharu ^a   Nakajima, Yoshiharu ^b   Hiyama, Akio ^a   Maeda, Osamu ^a   Asakura, Wataru ^a  

^a Nippon Chemiphar Co Ltd   (Japan)

^b FUJIREBIO INC   (Japan)

Author keywords

arginine vasopressin analog; avoidance behavior; cycloheximide; learning impairment; No. 302

Indexed keywords

ARGIPRESSIN DERIVATIVE; CYCLOHEXIMIDE;

ANIMAL EXPERIMENT; AVOIDANCE BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; LEARNING DISORDER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031081282     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86070-6     Document Type: Conference Paper

References (8)

1. [1] De Wied, D. and Bohus, B., Long-term and short-term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and α-MSH, Nature, 212 (1966) 1484-1486.
2. [2] Gash, D.M., Herman, J.P. and Thomas G.J., Vasopressin and animal behavior. In: D.M. Gash and G.J. Boer (Eds.), Vasopressin Principles and Properties, Plenum Press, New York, 1987, pp. 517-547.
3. [3] Jolles, J., Vasopressin and human behavior. In: D.M. Gash and G.J. Boer (Eds.), Vasopressin Principles and Properties, Plenum Press, New York, 1987, pp. 548-578.
4. [4] Burbach, J.P.H. and Liu, B., Measurement of vasopressin-converting aminopeptidase activity and vasopressin metabolites, Methods Enzymol., 168 (1989) 385-397.
5. [5] Burbach, J.P.H., Kovacs, G.L., De Wied, D., Van Nispen, J.W. and Greven, H.M., A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide, Science, 221 (1983) 1310-1312.
6. [6] De Wied, D., Gaffori, O., Burbach, J.P.H., Kovacs, G.L. and Van Ree, J.M., Structure activity relationship studies with C-terminal fragment of vasopressin and oxytocin on avoidance behaviors of rats, J. Pharmacol. Exp. Ther., 241 (1987) 268-274.
7. [7] Strupp, B.J., Improvement of memory by a vasopressin, Behav. Neurosci., 103 (1989) 743-754.
8. 6]AVP(4-9) on passive avoidance behavior, Jpn. J. Pharmacol., Suppl. 1, 64 (1994) 354P.